Evidence map›Paper›PMID 40861709›Full record

ArticleCureus2025

Osmotic Demyelination Syndrome in Hyperosmolar Hyperglycemic State With Contrasting Initial Sodium Levels: A Report of Two Cases.

Daigo Kasamatsu, Takefumi Tsunemitsu, Masaru Matsumoto, Takao Suzuki

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Daigo KasamatsuDepartment of Emergency and Critical Care Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, JPN.
Takefumi TsunemitsuDepartment of Emergency and Critical Care Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, JPN.
Masaru MatsumotoDepartment of Emergency and Critical Care Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, JPN.
Takao SuzukiDepartment of Emergency and Critical Care Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osmotic demyelination syndrome (ODS) is typically associated with rapid correction of severe hyponatremia but is a rare complication of hyperosmolar hyperglycemic state (HHS). We describe two cases of ODS developing in HHS with contrasting initial sodium levels: one with profound hyponatremia (Na 112 mmol/L, corrected 167 mmol/L) and the other with hypernatremia (Na 149 mmol/L, corrected 177 mmol/L). Both patients exhibited severe hyperglycemia (2,398 and 1,277 mg/dL, respectively) and marked hyperosmolality (387 and 421 mOsm/kg) and were managed with cautious correction rates (1.2 and 1.0 mOsm/kg/hour). Despite this, each patient developed ODS diagnosed by MRI on days three and seven, respectively. Neurological function gradually improved in both, with final modified Rankin Scale scores of 2 and 1, respectively. To our knowledge, this is the first case report to directly compare hyponatremic and hypernatremic ODS in the context of HHS. Severe hyperosmolality can itself trigger ODS, regardless of measured and corrected sodium levels or the rate of correction. Clinicians should maintain a low threshold for timely MRI in HHS patients with persistent or unexplained neurological deficits.

Indexed as

central pontine myelinolysis (cpm)diabetes mellitusextrapontine myelinolysis (epm)hyperosmolar hyperglycemic state (hhs)osmotic demyelination syndrome (ods)

Identifiers

PMID40861709
PMCPMC12376077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.